During the past decade, Lyndhurst Clinical Research conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 16 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 13 clinical trials were completed. i.e. 260% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lyndhurst Clinical Research" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Inovio Pharmaceuticals" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Becton, Dickinson and Company" with 2 trials sponsored and "Coloplast A/S" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lyndhurst Clinical Research" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Dr. Carpenter Maternal Fetal Medicine Clinic" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Houston Perinatal Associates" with 1 trials as a collaborator and "Lyndhurst Clinical Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Lyndhurst Clinical Research" are "Pelvic Organ Prolapse" (3 trials), "Stress Urinary Incontinence" (3 trials), "Cervical Dysplasia" (2 trials), "Cervical High Grade Squamous Intraepithelial Lesion" (2 trials) and "Endometriosis" (2 trials). Many other conditions were trialed in "Lyndhurst Clinical Research" in a lesser frequency.

Most popular intervention types in "Lyndhurst Clinical Research" are "Drug" (24 trials), "Device" (12 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "VGX-3100" (3 trials), "placebo" (3 trials), "Colposcopy" (2 trials) and "VT-1161" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lyndhurst Clinical Research" are 33 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Lyndhurst Clinical Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Lyndhurst Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Lyndhurst Clinical Research, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".